Ko W. Kim

Jeonju, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 63 publications

Multidomain Lifestyle Intervention in Mild Cognitive Impairment: Subgroup Analysis of the SUPERBRAIN-MEET Randomized Trial.

Multidomain Lifestyle Intervention in Mild Cognitive Impairment: Subgroup Analysis of the SUPERBRAIN-MEET Randomized Trial.

Journal: Neurology

Published: July 20, 2026

Perceptual-phase eye-tracking during figure copying is associated with amyloid-β PET positivity in mild cognitive impairment.

Perceptual-phase eye-tracking during figure copying is associated with amyloid-β PET positivity in mild cognitive impairment.

Journal: Journal of Alzheimer's disease : JAD

Published: June 24, 2026

Plasma Phosphorylated Tau 217 Cutoffs for Amyloid Pathology and Kidney Function, Body Mass Index, and Anemia.

Plasma Phosphorylated Tau 217 Cutoffs for Amyloid Pathology and Kidney Function, Body Mass Index, and Anemia.

Journal: JAMA neurology

Published: February 02, 2026

Metadata in Smartphone-Based Cognitive Assessments: Current State and Emerging Evidence in Psychiatric Disorders.

Metadata in Smartphone-Based Cognitive Assessments: Current State and Emerging Evidence in Psychiatric Disorders.

Journal: Harvard review of psychiatry

Published: May 30, 2025

Prognostic Value of A/T/N Biomarkers: Comparing Plasma and Imaging Modalities in Alzheimer Disease.

Prognostic Value of A/T/N Biomarkers: Comparing Plasma and Imaging Modalities in Alzheimer Disease.

Journal: Clinical nuclear medicine

Published: April 12, 2025

Potential utility of plasma pTau217 for assessing amyloid and tau biomarker profiles.

Potential utility of plasma pTau217 for assessing amyloid and tau biomarker profiles.

Journal: European journal of nuclear medicine and molecular imaging

Published: February 20, 2025

Temporal Dynamics and Biological Variability of Alzheimer Biomarkers.

Temporal Dynamics and Biological Variability of Alzheimer Biomarkers.

Journal: JAMA neurology

Published: February 17, 2025

Clinical Practice Guidelines for Dementia: Recommendations for Cholinesterase Inhibitors and Memantine.

Clinical Practice Guidelines for Dementia: Recommendations for Cholinesterase Inhibitors and Memantine.

Journal: Dementia and neurocognitive disorders

Published: December 11, 2024

Functional Near-Infrared Spectroscopy Signal as a Potential Biomarker for White Matter Hyperintensity Progression in Patients With Subcortical Vascular Cognitive Impairment: A Pilot Study.

Functional Near-Infrared Spectroscopy Signal as a Potential Biomarker for White Matter Hyperintensity Progression in Patients With Subcortical Vascular Cognitive Impairment: A Pilot Study.

Journal: Brain and behavior

Published: December 06, 2024

Clinical Practice Guidelines for Dementia: Recommendations for the Pharmacological Treatment of Behavioral and Psychological Symptoms.

Clinical Practice Guidelines for Dementia: Recommendations for the Pharmacological Treatment of Behavioral and Psychological Symptoms.

Journal: Dementia and neurocognitive disorders

Published: December 04, 2024

Association of peripheral neuropathy with dementia in type 2 diabetes: a 5-year follow-up study using the national health insurance service-national health information database.

Association of peripheral neuropathy with dementia in type 2 diabetes: a 5-year follow-up study using the national health insurance service-national health information database.

Journal: Endocrine

Published: November 16, 2024

Differential roles of Alzheimer's disease plasma biomarkers in stepwise biomarker-guided diagnostics.

Differential roles of Alzheimer's disease plasma biomarkers in stepwise biomarker-guided diagnostics.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: September 30, 2024

Showing 1-12 of 63

Last Updated: 09/26/2026